Cyclodextrins in Drug Delivery: an Updated Review

Overview

Journal AAPS PharmSciTech

Publisher Springer

Specialty Pharmacology

Date 2005 Dec 16

PMID 16353992

Citations 207

Authors

Rajeswari Challa

Alka Ahuja

Javed Ali

R K Khar

Affiliations

Soon will be listed here.

Abstract

The purpose of this review is to discuss and summarize some of the interesting findings and applications of cyclodextrins (CDs) and their derivatives in different areas of drug delivery, particularly in protein and peptide drug delivery and gene delivery. The article highlights important CD applications in the design of various novel delivery systems like liposomes, microspheres, microcapsules, and nanoparticles. In addition to their well-known effects on drug solubility and dissolution, bioavailability, safety, and stability, their use as excipients in drug formulation are also discussed in this article. The article also focuses on various factors influencing inclusion complex formation because an understanding of the same is necessary for proper handling of these versatile materials. Some important considerations in selecting CDs in drug formulation such as their commercial availability, regulatory status, and patent status are also summarized. CDs, because of their continuing ability to find several novel applications in drug delivery, are expected to solve many problems associated with the delivery of different novel drugs through different delivery routes.

Citing Articles

Stability and Properties of Ultraviolet Filter Avobenzone under Its Diketo/Enol Tautomerization Induced by Molecular Encapsulation with β-Cyclodextrin.

Kuroda C, Tsuchida T, Tsunoda C, Minamide M, Hiroshige R, Goto S Langmuir. 2025; 41(2):1429-1445.

PMID: 39772649 PMC: 11755785. DOI: 10.1021/acs.langmuir.4c04108.

Design, characterization, and evaluation of magnetic carboxymethylated β-cyclodextrin as a pH-sensitive carrier system for amantadine delivery: a novel approach for targeted drug delivery.

Hadadian M, Allahyari R, Mahdavi B, Rezaei-Seresht E RSC Adv. 2025; 15(1):446-459.

PMID: 39758925 PMC: 11698272. DOI: 10.1039/d4ra06269h.

Evaluation of Subetadex-α-methyl, a Polyanionic Cyclodextrin Scaffold, as a Medical Countermeasure against Fentanyl and Related Opioids.

Malfatti M, Enright H, McCloy S, Ubick E, Kuhn E, Subramanian A ACS Cent Sci. 2024; 10(12):2200-2212.

PMID: 39735318 PMC: 11672541. DOI: 10.1021/acscentsci.4c00682.

Anti-inflammatory effects of cyclodextrin nanoparticles enable macrophage repolarization and reduce inflammation.

Brettner F, Gier S, Haessler A, Schreiner J, Vogel-Kindgen S, Windbergs M Discov Nano. 2024; 19(1):211.

PMID: 39707045 PMC: 11662127. DOI: 10.1186/s11671-024-04175-6.

Enhancing Cannabinoid Bioavailability in Pain Management: The Role of Cyclodextrins.

Ribeiro A, Loureiro R, Cabral-Marques H Molecules. 2024; 29(22).

PMID: 39598730 PMC: 11596380. DOI: 10.3390/molecules29225340.

References

Suihko E, Korhonen O, Jarvinen T, Ketolainen J, Jarho P, Laine E . Complexation with tolbutamide modifies the physicochemical and tableting properties of hydroxypropyl-beta-cyclodextrin. Int J Pharm. 2001; 215(1-2):137-45. DOI: 10.1016/s0378-5173(00)00682-7. View

Croyle M, Cheng X, Wilson J . Development of formulations that enhance physical stability of viral vectors for gene therapy. Gene Ther. 2001; 8(17):1281-90. DOI: 10.1038/sj.gt.3301527. View

Otero-Espinar F, Blanco-Mendez J . Formulation of triamcinolone acetonide pellets suitable for coating and colon targeting. Int J Pharm. 1999; 179(2):229-35. DOI: 10.1016/s0378-5173(98)00369-x. View

Hwang S, Bellocq N, Davis M . Effects of structure of beta-cyclodextrin-containing polymers on gene delivery. Bioconjug Chem. 2001; 12(2):280-90. DOI: 10.1021/bc0001084. View

Babu R, Pandit J . Effect of aging on the dissolution stability of glibenclamide/beta-cyclodextrin complex. Drug Dev Ind Pharm. 1999; 25(11):1215-9. DOI: 10.1081/ddc-100102291. View

Stevens D . Itraconazole in cyclodextrin solution. Pharmacotherapy. 1999; 19(5):603-11. DOI: 10.1592/phco.19.8.603.31529. View

Zarzycki P, Lamparczyk H . The equilibrium constant of beta-cyclodextrin-phenolphtalein complex; influence of temperature and tetrahydrofuran addition. J Pharm Biomed Anal. 1998; 18(1-2):165-70. DOI: 10.1016/s0731-7085(98)00150-2. View

Blanco-Mendez J, Otero-Espinar F . Use of beta-cyclodextrins to prevent modifications of the properties of carbopol hydrogels due to carbopol-drug interactions. Chem Pharm Bull (Tokyo). 2002; 50(1):40-6. DOI: 10.1248/cpb.50.40. View

Loftsson T, Brewster M . Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J Pharm Sci. 1996; 85(10):1017-25. DOI: 10.1021/js950534b. View

10.

Sangalli M, Zema L, Maroni A, Foppoli A, Giordano F, Gazzaniga A . Influence of betacyclodextrin on the release of poorly soluble drugs from inert and hydrophilic heterogeneous polymeric matrices. Biomaterials. 2001; 22(19):2647-51. DOI: 10.1016/s0142-9612(01)00005-9. View

11.

Saarinen-Savolainen P, Jarvinen T, Araki-Sasaki K, Watanabe H, Urtti A . Evaluation of cytotoxicity of various ophthalmic drugs, eye drop excipients and cyclodextrins in an immortalized human corneal epithelial cell line. Pharm Res. 1998; 15(8):1275-80. DOI: 10.1023/a:1011956327987. View

12.

Pitha J, Harman S, Michel M . Hydrophilic cyclodextrin derivatives enable effective oral administration of steroidal hormones. J Pharm Sci. 1986; 75(2):165-7. DOI: 10.1002/jps.2600750213. View

13.

Chowdary K, Nalluri B . Nimesulide and beta-cyclodextrin inclusion complexes: physicochemical characterization and dissolution rate studies. Drug Dev Ind Pharm. 2000; 26(11):1217-20. DOI: 10.1081/ddc-100100995. View

14.

McCandless R, Yalkowsky S . Effect of hydroxypropyl-beta-cyclodextrin and pH on the solubility of levemopamil HCl. J Pharm Sci. 1999; 87(12):1639-42. DOI: 10.1021/js9802143. View

15.

Arias M, MOYANO J, Munoz P, Gines J, Justo A, Giordano F . Study of omeprazole-gamma-cyclodextrin complexation in the solid state. Drug Dev Ind Pharm. 2000; 26(3):253-9. DOI: 10.1081/ddc-100100353. View

16.

Pun S, Davis M . Development of a nonviral gene delivery vehicle for systemic application. Bioconjug Chem. 2002; 13(3):630-9. DOI: 10.1021/bc0155768. View

17.

Pina M, Veiga F . The influence of diluent on the release of theophylline from hydrophilic matrix tablets. Drug Dev Ind Pharm. 2000; 26(10):1125-8. DOI: 10.1081/ddc-100100279. View

18.

Blanchard J, Proniuk S . Some important considerations in the use of cyclodextrins. Pharm Res. 2000; 16(12):1796-8. DOI: 10.1023/a:1011930821801. View

19.

Bettinetti G, Mura P, Faucci M, Sorrenti M, Setti M . Interaction of naproxen with noncrystalline acetyl beta- and acetyl gamma-cyclodextrins in the solid and liquid state. Eur J Pharm Sci. 2002; 15(1):21-9. DOI: 10.1016/s0928-0987(01)00199-3. View

20.

Burgos A, Belchior J, Sinisterra R . Controlled release of rhodium (II) carboxylates and their association complexes with cyclodextrins from hydroxyapatite matrix. Biomaterials. 2002; 23(12):2519-26. DOI: 10.1016/s0142-9612(01)00386-6. View